Oncotelic Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2017
Period Ending	Apr '26 Apr 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2017
Market Capitalization	16	37	14	15	18	63	Upgrade
Market Cap Growth	-26.06%	160.46%	-6.64%	-13.25%	-71.94%	225.64%	Upgrade
Enterprise Value	29	50	26	27	27	70	Upgrade
Last Close Price	0.04	0.08	0.04	0.04	0.04	0.17	Upgrade
PE Ratio	0.06	0.15	-	-	3.45	-	Upgrade
PS Ratio	-	-	-	218.13	-	-	Upgrade
PB Ratio	0.06	0.14	1.91	1.32	0.92	7.69	Upgrade
P/TBV Ratio	0.06	0.14	2.61	2.49	2.40	-	Upgrade
EV/Sales Ratio	-	-	-	384.58	-	-	Upgrade
Debt / Equity Ratio	0.05	0.05	1.75	1.08	0.59	1.10	Upgrade
Net Debt / Equity Ratio	0.05	0.05	1.74	1.07	0.57	1.03	Upgrade
Net Debt / EBITDA Ratio	-	-	-	-22.47	-1.97	-0.93	Upgrade
Asset Turnover	-	-	-	0.00	-	-	Upgrade
Quick Ratio	0.01	0.01	0.01	0.01	0.02	0.04	Upgrade
Current Ratio	0.07	0.07	0.01	0.02	0.02	0.04	Upgrade
Return on Equity (ROE)	185.00%	185.00%	-50.08%	-53.28%	34.20%	-101.92%	Upgrade
Return on Assets (ROA)	-0.89%	-0.89%	-0.83%	-1.07%	-11.74%	-24.13%	Upgrade
Return on Invested Capital (ROIC)	-1.39%	-1.39%	-1.69%	-2.08%	-23.98%	-54.90%	Upgrade
Return on Capital Employed (ROCE)	-0.80%	-0.80%	-5.00%	-4.20%	-29.20%	-111.90%	Upgrade
Earnings Yield	1558.87%	671.40%	-31.74%	-51.76%	28.95%	-14.97%	Upgrade
Buyback Yield / Dilution	-4.12%	-4.12%	-5.29%	16.01%	-50.89%	-244.02%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.